Spelling suggestions: "subject:"varies."" "subject:"ovaries.""
51 |
Functional characterization of GRB7 and its variant, GRB7v, in ovariancancerWang, Yajun, 王亚君 January 2010 (has links)
published_or_final_version / Obstetrics and Gynaecology / Doctoral / Doctor of Philosophy
|
52 |
Dysregulated PAK4 and chemosensitivity in ovarian cancer: an in vitro studyChu, Chun-ho, Terence., 朱雋皞. January 2012 (has links)
Ovarian cancer is regarded as the most lethal gynecological malignancy around the
world. Despite the advancing medical improvements in both surgery and
chemotherapy, the mortality rate did not appear to be reduced. This could be
account for the late diagnosis of ovarian cancer until advanced stage. Recently, p-21
activated kinase 4 (PAK4), as a potential significant prognostic marker of ovarian
cancer, has been widely studied on its contribution in oncogenesis properties. It was
suggested that PAK4 proteins were activated and confer chemoresistance in ovarian
cancers.
In this study, we hypothesized that the up-regulation of PAK4 in ovarian cancers
maybe resulted from mutations and amplification in genomic DNA level.
Investigations on PAK4 genetic alterations were carried out. Recurrent mutations
were found in the kinase domain of PAK4 in three ovarian cancer cell lines and two
clinical samples. Single mutation was found in the exon 3 of PAK4 coding for
GTPase binding domain (GTB). Amplifications of PAK4 genomic DNA were also
found in four ovarian cancer cell lines.
On top of that, dysregulated PAK4 level in chemosensitivity ovarian cancer cell line,
A2780s showed PAK4 contribution in protection against apoptosis. Meanwhile
PAK4 transfected chemoresistance cell line A2780cp also showed similar effect to
PAK4 transfected A2780s. Kinase-dead and constitutively active PAK4 did not
show any significance contribution to the apoptosis property. This may suggest that
PAK4 do not operate all kinase domains towards apoptotic function. Immortalized
normal ovarian epithelial cell line, HOSE6-3 was also upregulated with PAK4
transfection. However it did not induce the oncogenesis property of cell survival. / published_or_final_version / Pathology / Master / Master of Medical Sciences
|
53 |
Genetic polymorphisms in ovarian cancer黎子韻, Lai, Tsz-wan, Kristi. January 2002 (has links)
published_or_final_version / Medical Sciences / Master / Master of Medical Sciences
|
54 |
Neuroendocrine effects on ovarian development in the crab Thalamita crenata Latreille studied in vitro / Ovarian development in the crabOyama, Stanley Nobuyuki January 1968 (has links)
Typescript. / Bibliography: leaves 67-69. / ix, 69 l illus., tables
|
55 |
Targetable biodegradable nanoparticles for delivery of chemotherapeutic and imaging agents to ovarian cancerBetancourt, Tania, January 1900 (has links)
Thesis (Ph. D.)--University of Texas at Austin, 2007. / Vita. Includes bibliographical references.
|
56 |
Brain-derived neurotrophic factor (BDNF)/tropomyosin-related kinase B (TRKB) signaling in ovarian cancerAu, Wing-han. January 2007 (has links)
Thesis (M. Phil.)--University of Hong Kong, 2008. / Also available in print.
|
57 |
Regulation of cadherins and catenins in ovarian surface epithelium and ovarian cancerPon, Yuen-lam. January 2007 (has links)
Thesis (Ph. D.)--University of Hong Kong, 2008. / Also available in print.
|
58 |
Molecular studies on endometrial and ovarian carcinogenesisChan, Kwan-yi, Queeny. January 2007 (has links)
Thesis (Ph. D.)--University of Hong Kong, 2008. / Also available in print.
|
59 |
Gene expression study in ovary cancerWong, Hung-lai. January 2008 (has links)
Thesis (M. Med. Sc.)--University of Hong Kong, 2008. / Includes bibliographical references (p. 67-75)
|
60 |
Exploring the therapeutic potential of novel molecular targeted therapies in treating human ovarian cancerKouadio, Ange S. January 2008 (has links)
Thesis (M.S.)--Villanova University, 2008. / Biology Dept. Includes bibliographical references.
|
Page generated in 0.0496 seconds